Product Specifications Compound: PT-141 (Bremelanotide) Class: Synthetic cyclic heptapeptide / -MSH analog Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH Molecular Weight: ~1025 Da Form: Lyophilized powder Vial Size: 10mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Context PT-141 is utilized in research applications involving peptide chemistry , melanocortin receptor pharmacology , and cellular research applications
Our manufacturing process is featured on the Gaia Peptides homepage, demonstrating our commitment to transparency, UK manufacturing and quality assurance
Vinaiphat A, Pazhanchamy K, JebaMercy G, Ngan SC, Leow MK, Ho HH, Gao YG, Lim KL, Richards AM, de Kleijn D, Chen CP, Kalaria RN, Liu J, OLeary DD, McCarthy NE, Sze SK
What once represented a specialized class of diabetes treatments has grown into one of the most consequential therapeutic categories in modern medicine, with GLP-1 receptor agonists now fundamentally restructuring how obesity, metabolic disease and potentially even neurodegeneration are treated
